Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9849169 MDR

Patent 9849169 was granted and assigned to Arsanis on December, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Gerhild Zauner0

Adriana Badarau0

Eszter Nagy0

Gábor Nagy0

Irina Mirkina0

Jolanta Lukasiewicz0

Luis Guachalla0

Valéria Szijárto0

...

Date of Patent

December 26, 2017

0

Patent Application Number

146511560

Date Filed

January 17, 2014

0

Patent Citations Received

US Patent 12128095 None

0

US Patent 12103962 None

0

US Patent 11931405 Bioconjugates of

0

US Patent 12076385 Methods and compositions for immune protection against extra-intestinal pathogenic

0

Patent Primary Examiner

0

Patent abstract

The subject relates to an isolated antibody that specifically binds to O25b antigen of multi drug resistant (MDR) E. coli strains, its medical and diagnostic use, method of producing the antibody, including an isolated nucleotide sequence, plasmids and host cells as used in the production of the antibody; and further an isolated epitope recognized the specific antibody.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9849169 MDR

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool